002550 千红制药
午间休市 11-18 11:30:00
资讯
新帖
简况
股市必读:千红制药(002550)11月11日披露最新机构调研信息
证券之星 · 11-12
股市必读:千红制药(002550)11月11日披露最新机构调研信息
股市必读:千红制药新发布《千红制药:北京国枫律师事务所关于常州千红生化制药股份有限公司向不特定对象发行可转换公司债券并申请在深圳证券交易所上市的法律意见书》
证券之星 · 11-11
股市必读:千红制药新发布《千红制药:北京国枫律师事务所关于常州千红生化制药股份有限公司向不特定对象发行可转换公司债券并申请在深圳证券交易所上市的法律意见书》
千红制药:原股东优先配售日需在T日手动操作并缴付足额资金
证券之星 · 11-10
千红制药:原股东优先配售日需在T日手动操作并缴付足额资金
股市必读:千红制药新发布《千红制药:北京国枫律师事务所关于常州千红生化制药股份有限公司向不特定对象发行可转换公司债券并申请在深圳证券交易所上市的法律意见书》
证券之星 · 11-10
股市必读:千红制药新发布《千红制药:北京国枫律师事务所关于常州千红生化制药股份有限公司向不特定对象发行可转换公司债券并申请在深圳证券交易所上市的法律意见书》
千红制药(002550)披露向不特定对象发行可转债获证监会注册,11月09日股价下跌0.93%
证券之星 · 11-09
千红制药(002550)披露向不特定对象发行可转债获证监会注册,11月09日股价下跌0.93%
股市必读:千红制药新发布《千红制药:关于参加2026年常州上市公司投资者集体接待日活动的公告》
证券之星 · 11-06
股市必读:千红制药新发布《千红制药:关于参加2026年常州上市公司投资者集体接待日活动的公告》
千红制药(002550)披露将参加2026年常州上市公司投资者集体接待日活动,11月04日股价上涨1.61%
证券之星 · 11-04
千红制药(002550)披露将参加2026年常州上市公司投资者集体接待日活动,11月04日股价上涨1.61%
股市必读:千红制药新发布《2026年三季度报告》
证券之星 · 11-02
股市必读:千红制药新发布《2026年三季度报告》
千红制药涨5.40%,东海证券二个月前给出“买入”评级
证券之星 · 10-30
千红制药涨5.40%,东海证券二个月前给出“买入”评级
千红制药(002550)10月30日主力资金净买入1580.72万元
证券之星 · 10-30
千红制药(002550)10月30日主力资金净买入1580.72万元
千红制药:千红配债将尽快申请上市交易
证券之星 · 10-30
千红制药:千红配债将尽快申请上市交易
股市必读:千红制药三季报 - 第三季度单季净利润同比下降50.20%
证券之星 · 10-30
股市必读:千红制药三季报 - 第三季度单季净利润同比下降50.20%
千红制药(002550.SZ)发布前三季度业绩,归母净利润2.15亿元,同比下降43.86%
智通财经 · 10-29
千红制药(002550.SZ)发布前三季度业绩,归母净利润2.15亿元,同比下降43.86%
千红制药(002550)10月27日主力资金净卖出1136.99万元
证券之星 · 10-27
千红制药(002550)10月27日主力资金净卖出1136.99万元
千红制药:QHRD106注射液项目处于Ⅱb期临床收尾阶段
格隆汇 · 10-27
千红制药:QHRD106注射液项目处于Ⅱb期临床收尾阶段
股市必读:千红制药新发布《千红制药:第六届董事会第十五次会议决议公告》
证券之星 · 10-26
股市必读:千红制药新发布《千红制药:第六届董事会第十五次会议决议公告》
千红制药(002550)披露向不特定对象发行可转换公司债券方案,10月23日股价上涨1.46%
证券之星 · 10-23
千红制药(002550)披露向不特定对象发行可转换公司债券方案,10月23日股价上涨1.46%
股市必读:千红制药新发布《千红制药:第六届董事会第十五次会议决议公告》
证券之星 · 10-23
股市必读:千红制药新发布《千红制药:第六届董事会第十五次会议决议公告》
千红制药:拟发行10亿元可转债
每日经济新闻 · 10-22
千红制药:拟发行10亿元可转债
股市必读:千红制药(002550)10月15日董秘有最新回复
证券之星 · 10-16
股市必读:千红制药(002550)10月15日董秘有最新回复
加载更多
公司概况
公司名称:
常州千红生化制药股份有限公司
所属行业:
医药制造业
上市日期:
2011-02-18
主营业务:
常州千红生化制药股份有限公司的主营业务是生物医药品的研发、生产和销售。公司的主要产品是肝素钠系列、依诺肝素系列、达肝素钠系列、那屈肝素钙系列、胰激肽原酶系列、复方消化酶胶囊(II)、门冬酰胺酶系列、弹性酶系列、肠衣系列。公司是国家级高新技术企业,获得了全国总工会授予的“全国五一劳动奖状”以及江苏省总工会授予的“模范职工之家”、“江苏省最美职工之家”称号。
发行价格:
32.00
{"stockData":{"symbol":"002550","market":"SZ","secType":"STK","nameCN":"千红制药","latestPrice":6.11,"timestamp":1794974391000,"preClose":6.22,"halted":0,"volume":4561100,"delay":0,"changeRate":-0.0177,"floatShares":953999999,"shares":1280000000,"eps":0.1803,"marketStatus":"午间休市","change":-0.11,"latestTime":"11-18 11:30:00","open":6.22,"high":6.27,"low":6.11,"amount":28172400,"amplitude":0.0257,"askPrice":6.12,"askSize":182,"bidPrice":6.11,"bidSize":709,"shortable":0,"etf":0,"ttmEps":0.1803,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794978000000},"marketStatusCode":3,"adr":0,"adjPreClose":6.22,"symbolType":"stock","openAndCloseTimeList":[[1794965400000,1794972600000],[1794978000000,1794985200000]],"highLimit":6.84,"lowLimit":5.6,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1279800000,"isCdr":false,"pbRate":2.84,"roa":"--","peRate":33.887965,"roe":"7.71%","epsLYR":0.32,"committee":0.538612,"marketValue":7820000000,"turnoverRate":0.0048,"status":1,"floatMarketCap":5826000000},"requestUrl":"/m/hq/s/002550","defaultTab":"news","newsList":[{"id":"2682581355","title":"股市必读:千红制药(002550)11月11日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2682581355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682581355?lang=zh_cn&edition=full","pubTime":"2026-11-12 02:08","pubTimestamp":1794420498,"startTime":"0","endTime":"0","summary":"截至2026年11月11日收盘,千红制药报收于6.35元,下跌0.47%,换手率0.73%,成交量6.97万手,成交额4432.04万元。机构调研要点:河南千牧肝素粗品产线收率已达行业平均水平以上,符合预期;依诺肝素钠纳入第八批集采续标后,2026年二季度起销量与销售额同比均增长。关于依诺肝素钠集采落地:2026年二季度纳入国家第八批集采续标,目前销量与销售额相比去年同期均有增长。关于方圆制药重整:项目正有序推进,重要进展将依规及时披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200002225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682348975","title":"股市必读:千红制药新发布《千红制药:北京国枫律师事务所关于常州千红生化制药股份有限公司向不特定对象发行可转换公司债券并申请在深圳证券交易所上市的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682348975","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682348975?lang=zh_cn&edition=full","pubTime":"2026-11-11 03:26","pubTimestamp":1794338815,"startTime":"0","endTime":"0","summary":"公司公告汇总千红制药:北京国枫律师事务所关于常州千红生化制药股份有限公司向不特定对象发行可转换公司债券并申请在深圳证券交易所上市的法律意见书北京国枫律师事务所确认千红制药向不特定对象发行可转换公司债券已获董事会、股东大会批准,并经深交所审核通过及中国证监会同意注册;发行人具备合法主体资格,符合《公司法》《证券法》《管理办法》等发行实质条件,尚需取得深交所上市审核同意。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100007726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","399001","002550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682352860","title":"千红制药:原股东优先配售日需在T日手动操作并缴付足额资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2682352860","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682352860?lang=zh_cn&edition=full","pubTime":"2026-11-10 11:36","pubTimestamp":1794281808,"startTime":"0","endTime":"0","summary":"证券之星消息,千红制药(002550)11月09日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,不好意思!请问一下董秘,第一次配债不懂的操作,没有手动买入,以为钱放在账户里会直接扣款,现在可以再申请吗?千红制药回复:尊敬的投资者,您好,原股东优先配售日需在T日(2026年10月27日)申购时通过深交所交易系统手动操作并缴付足额资金,账户资金不会自动扣款。若您未在优先认购时间内完成申购,该优先配售权益已无法补办。感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000014938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682333089","title":"股市必读:千红制药新发布《千红制药:北京国枫律师事务所关于常州千红生化制药股份有限公司向不特定对象发行可转换公司债券并申请在深圳证券交易所上市的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682333089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682333089?lang=zh_cn&edition=full","pubTime":"2026-11-10 02:57","pubTimestamp":1794250654,"startTime":"0","endTime":"0","summary":"公司公告汇总千红制药:北京国枫律师事务所关于常州千红生化制药股份有限公司向不特定对象发行可转换公司债券并申请在深圳证券交易所上市的法律意见书北京国枫律师事务所确认千红制药向不特定对象发行可转换公司债券已获董事会、股东大会批准,并经深交所审核通过及中国证监会同意注册;发行人具备合法主体资格,符合《公司法》《证券法》《管理办法》等关于发行可转债的实质条件,尚需取得深交所上市审核同意。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000003283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","399001","002550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682843353","title":"千红制药(002550)披露向不特定对象发行可转债获证监会注册,11月09日股价下跌0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682843353","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682843353?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:47","pubTimestamp":1794235669,"startTime":"0","endTime":"0","summary":"截至2026年11月9日收盘,千红制药报收于6.39元,较前一交易日下跌0.93%,最新总市值为81.78亿元。该股当日开盘6.48元,最高6.49元,最低6.35元,成交额达7501.07万元,换手率为1.23%。近日,千红制药发布《华泰联合证券有限责任公司关于常州千红生化制药股份有限公司向不特定对象发行可转换公司债券并在主板上市之上市保荐书》。公告显示,本次发行可转债总额10亿元,期限六年,募集资金用于创新药研发、原料药生产基地建设及补充流动资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900024584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681100387","title":"股市必读:千红制药新发布《千红制药:关于参加2026年常州上市公司投资者集体接待日活动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2681100387","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681100387?lang=zh_cn&edition=full","pubTime":"2026-11-06 01:02","pubTimestamp":1793898141,"startTime":"0","endTime":"0","summary":"截至2026年11月5日收盘,千红制药报收于6.46元,上涨2.54%,换手率1.63%,成交量15.5万手,成交额9914.48万元。当日关注点交易信息汇总:11月5日主力资金净流入1785.48万元,占总成交额18.01%; 公司公告汇总:千红制药将于2026年11月10日16:00–17:00通过网络远程方式参加常州上市公司投资者集体接待日活动。活动时间为2026年11月10日16:00–17:00,公司将在现场就发展战略、公司治理、经营状况等与投资者进行交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600001617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680057018","title":"千红制药(002550)披露将参加2026年常州上市公司投资者集体接待日活动,11月04日股价上涨1.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680057018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680057018?lang=zh_cn&edition=full","pubTime":"2026-11-04 22:19","pubTimestamp":1793801987,"startTime":"0","endTime":"0","summary":"截至2026年11月4日收盘,千红制药报收于6.3元,较前一交易日上涨1.61%,最新总市值为80.63亿元。该股当日开盘6.21元,最高6.32元,最低6.18元,成交额达1.24亿元,换手率为2.08%。近日,千红制药发布《关于参加2026年常州上市公司投资者集体接待日活动的公告》。公告显示,公司将于2026年11月10日16:00-17:00通过网络远程方式参加2026年常州上市公司投资者集体接待日活动,投资者可通过全景路演网站、微信公众号或APP参与。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400043733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680200345","title":"股市必读:千红制药新发布《2026年三季度报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680200345","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680200345?lang=zh_cn&edition=full","pubTime":"2026-11-02 04:20","pubTimestamp":1793564419,"startTime":"0","endTime":"0","summary":"公司公告汇总2026年三季度报告2026年第三季度营业收入395,734,419.25元,同比增长12.03%;归属于上市公司股东的净利润62,332,207.41元,同比下降50.20%。千红制药:第六届董事会第十六次会议决议公告常州千红生化制药股份有限公司于2026年10月28日召开第六届董事会第十六次会议,审议通过《公司2026年第三季度报告的议案》《关于拟注销部分回购股份暨减少注册资本、修订〈公司章程〉的议案》及《关于召开公司2026年第一次临时股东会通知的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200001307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679963332","title":"千红制药涨5.40%,东海证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2679963332","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679963332?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:10","pubTimestamp":1793351459,"startTime":"0","endTime":"0","summary":"今日千红制药涨5.40%,收盘报6.05元。2026年8月14日,东海证券研究员杜永宏发布了对千红制药的研报《公司简评报告:制剂业务整体平稳,原料药业务下滑》,该研报对千红制药给出“买入”评级。公司致力于打造传统业务全产业链优势,同时积极布局创新业务,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为平安证券的臧文清。千红制药个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000041948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679262934","title":"千红制药(002550)10月30日主力资金净买入1580.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679262934","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679262934?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:29","pubTimestamp":1793345367,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月30日收盘,千红制药报收于6.05元,上涨5.4%,换手率3.97%,成交量37.86万手,成交额2.28亿元。10月30日的资金流向数据方面,主力资金净流入1580.72万元,占总成交额6.94%,游资资金净流出310.76万元,占总成交额1.36%,散户资金净流出1269.95万元,占总成交额5.57%。该股最近90天内共有1家机构给出评级,买入评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000033414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679264653","title":"千红制药:千红配债将尽快申请上市交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2679264653","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679264653?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:06","pubTimestamp":1793343982,"startTime":"0","endTime":"0","summary":"证券之星消息,千红制药(002550)10月30日在投资者关系平台上答复投资者关心的问题。投资者提问:请问千红配债可以上市交易吗千红制药回复:尊敬的投资者,您好,“千红配债”是原股东优先配售的简称,本次发行的可转换公司债券不设持有期限制。发行结束后,公司将尽快向深圳证券交易所申请上市交易,具体上市时间将另行公告。感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000032483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679539732","title":"股市必读:千红制药三季报 - 第三季度单季净利润同比下降50.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679539732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679539732?lang=zh_cn&edition=full","pubTime":"2026-10-30 07:51","pubTimestamp":1793317889,"startTime":"0","endTime":"0","summary":"公司公告汇总:千红制药拟注销回购专用账户中剩余1800万股股份,总股本将由12.798亿股减至12.618亿股,尚需提交股东大会审议。2026年第三季度单季度主营收入3.96亿元,同比上升12.03%;单季度归母净利润6233.22万元,同比下降50.2%;单季度扣非净利润5807.95万元,同比下降19.74%;负债率14.02%,毛利率53.21%。公司公告汇总2026年三季度报告2026年第三季度营业收入3.96亿元,同比增长12.03%;归母净利润6233.22万元,同比下降50.20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000014261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679471097","title":"千红制药(002550.SZ)发布前三季度业绩,归母净利润2.15亿元,同比下降43.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679471097","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679471097?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:01","pubTimestamp":1793268096,"startTime":"0","endTime":"0","summary":"智通财经APP讯,千红制药(002550.SZ)发布2026年第三季度报告,公司前三季度实现营业收入11.54亿元,同比下降5.01%;归属于上市公司股东的净利润2.15亿元,同比下降43.86%;归属于上市公司股东的扣除非经常性损益的净利润2亿元,同比下降26.13%;基本每股收益0.1709元。报告期内,营业收入较上年同期下降5.01%,主要原因是本报告期内受海外市场整体需求影响,肝素原料药业务较去年同期出现下滑所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515236.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678125146","title":"千红制药(002550)10月27日主力资金净卖出1136.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678125146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678125146?lang=zh_cn&edition=full","pubTime":"2026-10-27 15:35","pubTimestamp":1793086543,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月27日收盘,千红制药报收于5.75元,下跌7.26%,换手率2.97%,成交量28.34万手,成交额1.67亿元。10月27日的资金流向数据方面,主力资金净流出1136.99万元,占总成交额6.81%,游资资金净流出287.46万元,占总成交额1.72%,散户资金净流入1424.45万元,占总成交额8.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700024364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678144476","title":"千红制药:QHRD106注射液项目处于Ⅱb期临床收尾阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2678144476","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678144476?lang=zh_cn&edition=full","pubTime":"2026-10-27 12:37","pubTimestamp":1793075837,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","002550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678413676","title":"股市必读:千红制药新发布《千红制药:第六届董事会第十五次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678413676","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678413676?lang=zh_cn&edition=full","pubTime":"2026-10-26 03:27","pubTimestamp":1792956428,"startTime":"0","endTime":"0","summary":"公司公告汇总千红制药:第六届董事会第十五次会议决议公告审议通过《关于进一步明确公司向不特定对象发行可转换公司债券方案的议案》,明确发行总额10亿元,每张面值100元,期限6年,初始转股价格6.42元/股,债券评级AA,不提供担保;同时审议通过可转债上市、募集资金专项账户设立等相关议案;本次发行无需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600000893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677592384","title":"千红制药(002550)披露向不特定对象发行可转换公司债券方案,10月23日股价上涨1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677592384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677592384?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:12","pubTimestamp":1792750359,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘,千红制药报收于6.27元,较前一交易日上涨1.46%,最新总市值为80.24亿元。该股当日开盘6.15元,最高6.27元,最低6.01元,成交额达1.49亿元,换手率为2.54%。千红制药于近日披露《第六届董事会第十五次会议决议公告》,审议通过《关于进一步明确公司向不特定对象发行可转换公司债券方案的议案》。同时,会议审议通过可转债上市、募集资金专项账户设立等相关议案。本次发行无需提交股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300033796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677399552","title":"股市必读:千红制药新发布《千红制药:第六届董事会第十五次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677399552","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677399552?lang=zh_cn&edition=full","pubTime":"2026-10-23 03:25","pubTimestamp":1792697153,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘,千红制药报收于6.18元,下跌1.44%,换手率0.7%,成交量6.65万手,成交额4139.77万元。公司公告汇总千红制药:第六届董事会第十五次会议决议公告审议通过《关于进一步明确公司向不特定对象发行可转换公司债券方案的议案》,明确发行总额10亿元,每张面值100元,期限6年,初始转股价格6.42元/股,债券评级AA,不提供担保;同时审议通过可转债上市、募集资金专项账户设立等相关议案;本次发行无需提交股东大会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300004006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677195963","title":"千红制药:拟发行10亿元可转债","url":"https://stock-news.laohu8.com/highlight/detail?id=2677195963","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677195963?lang=zh_cn&edition=full","pubTime":"2026-10-22 20:31","pubTimestamp":1792672260,"startTime":"0","endTime":"0","summary":"每经AI快讯,10月22日,千红制药公告,公司拟向不特定对象发行可转换公司债券,发行总金额为10亿元,发行数量为1000万张,每张面值100元;申购日为2026年10月27日(T日)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-10-22/doc-iniwchpf5858059.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-10-22/doc-iniwchpf5858059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002550","BK0239","FCEF","SABA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675378532","title":"股市必读:千红制药(002550)10月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2675378532","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675378532?lang=zh_cn&edition=full","pubTime":"2026-10-16 02:53","pubTimestamp":1792090387,"startTime":"0","endTime":"0","summary":"截至2026年10月15日收盘,千红制药报收于6.15元,下跌1.76%,换手率0.97%,成交量9.23万手,成交额5728.48万元。董秘最新回复投资者: 尊敬的董秘:您好!董秘: 尊敬的股东,您好,该创新药I类沟通交流会议为公司QHRD211项目,具体临床进展敬情关注公司后续信披披露相关公告,感谢您的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600002559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794974446008,"stockEarnings":[{"period":"1week","weight":-0.0251},{"period":"1month","weight":-0.0064},{"period":"3month","weight":-0.1037},{"period":"6month","weight":-0.0155},{"period":"1year","weight":-0.2882},{"period":"ytd","weight":-0.1896}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":-0.0354},{"period":"3month","weight":-0.0796},{"period":"6month","weight":-0.1208},{"period":"1year","weight":-0.0975},{"period":"ytd","weight":-0.0968}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"常州千红生化制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"72952人(较上一季度增加2.91%)","perCapita":"13071股","listingDate":"2011-02-18","address":"江苏省常州市新北区云河路518号","registeredCapital":"127980万元","survey":" 常州千红生化制药股份有限公司的主营业务是生物医药品的研发、生产和销售。公司的主要产品是肝素钠系列、依诺肝素系列、达肝素钠系列、那屈肝素钙系列、胰激肽原酶系列、复方消化酶胶囊(II)、门冬酰胺酶系列、弹性酶系列、肠衣系列。公司是国家级高新技术企业,获得了全国总工会授予的“全国五一劳动奖状”以及江苏省总工会授予的“模范职工之家”、“江苏省最美职工之家”称号。","listedPrice":32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"千红制药(002550)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供千红制药(002550)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"千红制药,002550,千红制药股票,千红制药股票老虎,千红制药股票老虎国际,千红制药行情,千红制药股票行情,千红制药股价,千红制药股市,千红制药股票价格,千红制药股票交易,千红制药股票购买,千红制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"千红制药(002550)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供千红制药(002550)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}